CYTOCARE 516 is a resorbable implant composed of Hyaluronic acid + Rejuvenating complex, injectable by micro-injections into into superficial dermis and medium dermis of peri-orbital and perioral lines (vertical lip lines). CYTOCARE 516 improves skin quality of moderate skin type: Filling fine lines, maintaining hydration, maintaining radiance.
€173.00
Produktinformationen
Active substances | NON CROSSLINKED HYALURONIC ACID, CT50 |
---|---|
Manufacturer | Laboratoires Revitacare |
Pack size | 10 x 5ml Vials |
Strength | 16mg/5ml |
Kinami Health gewährleistet eine schnelle und sichere Lieferung für Kliniken, Krankenhäuser und Kosmetiker. Profitieren Sie von schnellem und zuverlässigem Versand, damit Ihre Bestellungen schnell eintreffen. Unsere sichere Verpackung garantiert, dass die Produkte unbeschädigt und gebrauchsfertig bei Ihnen ankommen.
Wir liefern ausschließlich originale medizinische und ästhetische Produkte direkt von vertrauenswürdigen Herstellern. Jeder Artikel wird einer Qualitätskontrolle unterzogen, um Sicherheit, Wirksamkeit und Einhaltung von Industriestandards zu gewährleisten. Erhalten Sie Premiumprodukte zu wettbewerbsfähigen Preisen.
Unsere Vertriebsmitarbeiter helfen Ihnen, die optimale Lösung für Ihre Praxis zu finden. Ob Produktempfehlungen, Mengenrabatte oder Unterstützung bei der Bestellung – wir sind nur einen Anruf oder eine Nachricht entfernt.
Treue Kunden genießen bevorzugten Service, frühzeitigen Zugang zu neuen Produkten und exklusive Rabatte. Wir schätzen Ihr Geschäft und stellen sicher, dass Sie die besten Angebote und die beste Unterstützung erhalten, um Ihr Unternehmen weiterzuentwickeln.
CYTOCARE 516 is a professional-grade mesotherapy product created for aesthetic practitioners seeking effective skin rejuvenation treatments. This resorbable implant combines hyaluronic acid with an advanced rejuvenating complex to address early signs of aging through targeted micro-injections. The product delivers comprehensive skin improvement by enhancing hydration, texture, and overall skin radiance in patients with moderate aging concerns.
Professional administration of CYTOCARE 516 involves precise injection techniques into the superficial to medium dermis. Practitioners can utilize manual injection methods or automated devices, employing techniques such as retrotracing, cross-hatching, or point-by-point application.
The recommended treatment protocol consists of three sessions, spaced three weeks apart, followed by maintenance treatments every three months. Each injection should target the appropriate dermal layer for optimal therapeutic outcomes.
CYTOCARE 516 contains a scientifically formulated combination of active ingredients. The primary component includes 16mg of non-crosslinked hyaluronic acid per 5 ml vial, providing essential skin hydration properties. The proprietary rejuvenating complex CT50 incorporates vitamins, minerals, and amino acids that support cellular metabolism and collagen synthesis. Additional buffered preservation media ensure product stability and safety for clinical applications.
Proper storage of CYTOCARE 516 ensures product integrity and therapeutic efficacy. Store vials in refrigerated conditions between 2 °C and 8°C, protecting them from direct light exposure. Avoid freezing temperatures that may compromise the hyaluronic acid structure. Practitioners should verify expiration dates and adhere to cold chain protocols during transport and storage to maintain optimal product performance.
CYTOCARE 516 treatment is contraindicated in specific patient populations and conditions. Pregnant and breastfeeding women should not receive treatment due to safety considerations. Patients with known allergies to hyaluronic acid or rejuvenating complex components require alternative treatments. Areas previously treated with permanent implants or active skin infections present additional contraindications for CYTOCARE therapy.
Medical professionals must observe essential precautions when administering CYTOCARE 516 treatments. Avoid injection into muscles, blood vessels, bones, tendons, or ligaments to prevent complications. Patients should refrain from applying makeup for 12 hours post-treatment and limit UV exposure for 2 weeks. Single-use vials require proper disposal according to local regulations, and practitioners should never reuse solutions from opened containers.
Laboratoires Revitacare manufactures CYTOCARE 516 as a Class III medical device with CE certification obtained in 2009. The company’s expertise in aesthetic innovations ensures consistent product quality and compliance with regulatory standards.
Healthcare professionals can order CYTOCARE 516 through authorized distributors, with each package containing 10 x 5ml vials, traceability labels, and comprehensive package insert documentation. When practitioners buy CYTOCARE 516, they receive authentic products backed by manufacturer guarantees and regulatory approval for professional aesthetic applications.
CYTOCARE 516 serves as a specialized dermal treatment for addressing fine lines and early signs of aging in the peri-orbital and perioral regions. Medical professionals utilize this hyaluronic acid-based solution to restore skin vitality through superficial and medium dermal injections. The treatment targets vertical lip lines and delicate eye area concerns, making it an essential addition to aesthetic practice products.
The rejuvenating complex in CYTOCARE 516 provides multiple therapeutic advantages for practitioners and their clients. Enhanced skin hydration occurs through the 16mg hyaluronic acid concentration, while amino acids support cellular regeneration processes.
The treatment enhances skin elasticity, promotes natural skin radiance, and provides superior antioxidant protection compared to conventional hyaluronic acid solutions. Results include restored tonicity, improved texture, and visible skin rejuvenation that lasts several months.
Common side effects associated with CYTOCARE 516 treatment remain mild and temporary. Patients may experience slight tingling sensations, localized inflammation, or redness at the injection site. Small hematomas and mild edema can occur following treatment, but they typically resolve within a few days. Practitioners should inform patients about the expected reactions and provide them with appropriate post-treatment care instructions to minimize adverse effects.
Kinami Health prides itself on supplying genuine, high-quality medical injectables and supplies to hospitals, medical clinics, and licensed medical professionals around the world.
Pay easily with trusted providers
Links
Working Hours
Monday – Saturday
7 AM – 11 PM (CET)
Contact
UK: +44 7488 890499
Spain: +34 518 89 82 11
HongKong: +852 5808 0345
Email: [email protected]
Our Location
Room 4, Office 18, Block 19, Vicenti Building,
Triq Id-Dejqa, Valletta, VLT 1431, Malta
**We guarantee that you will receive your order. If your parcel does not make it to your doorstep, we will send you the order free of charge.
*** Information on this site is provided for informational purposes only. The use of some of the products included on this website should always be supervised and in any case be prescribed by a physician. It is not meant to substitute for the advice provided by your own physician or other medical professional. If you have or suspect that you have a medical problem, promptly contact your health care provider. The products must be used according to the information provided by manufacturers printed in brochures and on the packaging of the products. You should carefully read all product packaging, and contact the manufacturer with any questions before using a product.
*All products found on Kinamihealth.com are 100% authentic. The brands are trademarked and owned by their original manufacturers. Please note that this website is not affiliated with these manufacturers. Product packaging may not look exactly as seen here.
© 2025. All rights reserved